| Dr Chad R Gordon, DO | |
|
Department Of Plastic Surgery Johns Hopkins, Jhoc #8152f, 601 N. Caroline Street, Baltimore, MD 21287-0001 | |
| (443) 287-6425 | |
| Not Available |
| Full Name | Dr Chad R Gordon |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 27 Years |
| Location | Department Of Plastic Surgery Johns Hopkins, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952583932 | NPI | - | NPPES |
| 52189 | Medicaid | MD | |
| MB07654400 | Other | NJ | NEW JERSEY LICENSE NUMBER |
| 242456 | Other | MA | MASSACHUSETTS STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 242456 (Massachusetts) | Secondary |
| 208200000X | Plastic Surgery | H72202 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johns Hopkins Hospital, The | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
Biotech company Pharming Group NV ("Pharming" or the "Company") has received commitment from bondholders, representing 70% of the nominal amount of the currently outstanding bonds, to accept the offer to convert the bonds as announced on September 21, 2009. Together, they exceed the threshold level of 60% which Pharming set as a minimum participation in order to execute the transaction.
Ore Pharmaceuticals Inc., announced today the publication of an article in the online version of the journal Inflammation Research titled, "Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice."
To further bolster its commitment to environmental sustainability, Cardinal Health today announced that it has joined Practice Greenhealth, a membership organization for institutions and businesses in the health care field who are engaged in reducing their environmental footprints.
new study by researchers at the University of Iowa Hospitals and Clinics found that thigh muscle strength does not predict the occurrence of knee osteoarthritis (OA) uncovered in x-rays, but does predict incidence of painful or stiff knee OA. Women with the strongest quadriceps muscles appeared to be protected against the development of knee OA symptoms. Details of this study appear in the September issue of Arthritis Care & Research.
Myriad Genetics, Inc. announced today that a study published in Lancet Oncology shows the Company's 46-gene PROLARIS™ molecular diagnostic test significantly predicts prostate cancer outcome.
› Verified 3 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
Biotech company Pharming Group NV ("Pharming" or the "Company") has received commitment from bondholders, representing 70% of the nominal amount of the currently outstanding bonds, to accept the offer to convert the bonds as announced on September 21, 2009. Together, they exceed the threshold level of 60% which Pharming set as a minimum participation in order to execute the transaction.
Ore Pharmaceuticals Inc., announced today the publication of an article in the online version of the journal Inflammation Research titled, "Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice."
To further bolster its commitment to environmental sustainability, Cardinal Health today announced that it has joined Practice Greenhealth, a membership organization for institutions and businesses in the health care field who are engaged in reducing their environmental footprints.
new study by researchers at the University of Iowa Hospitals and Clinics found that thigh muscle strength does not predict the occurrence of knee osteoarthritis (OA) uncovered in x-rays, but does predict incidence of painful or stiff knee OA. Women with the strongest quadriceps muscles appeared to be protected against the development of knee OA symptoms. Details of this study appear in the September issue of Arthritis Care & Research.
Myriad Genetics, Inc. announced today that a study published in Lancet Oncology shows the Company's 46-gene PROLARIS™ molecular diagnostic test significantly predicts prostate cancer outcome.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chad R Gordon, DO 601 N. Caroline Street, Jhoc #8152f, Department Of Plastic Surgery, Johns Hopkins University, Baltimore, MD 21287 Ph: (443) 287-6425 | Dr Chad R Gordon, DO Department Of Plastic Surgery Johns Hopkins, Jhoc #8152f, 601 N. Caroline Street, Baltimore, MD 21287-0001 Ph: (443) 287-6425 |
News Archive
Biotech company Pharming Group NV ("Pharming" or the "Company") has received commitment from bondholders, representing 70% of the nominal amount of the currently outstanding bonds, to accept the offer to convert the bonds as announced on September 21, 2009. Together, they exceed the threshold level of 60% which Pharming set as a minimum participation in order to execute the transaction.
Ore Pharmaceuticals Inc., announced today the publication of an article in the online version of the journal Inflammation Research titled, "Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice."
To further bolster its commitment to environmental sustainability, Cardinal Health today announced that it has joined Practice Greenhealth, a membership organization for institutions and businesses in the health care field who are engaged in reducing their environmental footprints.
new study by researchers at the University of Iowa Hospitals and Clinics found that thigh muscle strength does not predict the occurrence of knee osteoarthritis (OA) uncovered in x-rays, but does predict incidence of painful or stiff knee OA. Women with the strongest quadriceps muscles appeared to be protected against the development of knee OA symptoms. Details of this study appear in the September issue of Arthritis Care & Research.
Myriad Genetics, Inc. announced today that a study published in Lancet Oncology shows the Company's 46-gene PROLARIS™ molecular diagnostic test significantly predicts prostate cancer outcome.
› Verified 3 days ago
Derek Lee Masden, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 N Calvert St, Baltimore, MD 21218 Phone: 585-233-9659 | |
Dr. Bao-quynh Thuy Julian, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St # 8161, Baltimore, MD 21287 Phone: 443-997-9466 Fax: 410-614-4333 | |
Jonathan Eitan Miller, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-9441 | |
Dr. Joseph C Orlando, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5601 Loch Raven Blvd, Suite 101, Pob, Baltimore, MD 21239 Phone: 410-433-4300 Fax: 410-433-4491 | |
Kerry Elizabeth Owens, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Frederick Rd, Suite 200, Baltimore, MD 21228 Phone: 410-744-0900 Fax: 410-744-3160 | |
Dr. James P. Higgins, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 N Calvert St, 2nd Fl, Baltimore, MD 21218 Phone: 410-235-5405 | |
Maakan Taghizadeh, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 300 Frederick Rd, Suite 200, Baltimore, MD 21228 Phone: 410-744-0900 Fax: 410-744-3160 |